N. P. Tasli Et Al. , "Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2," FRONTIERS IN IMMUNOLOGY , vol.13, 2022
Tasli, N. P. Et Al. 2022. Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2. FRONTIERS IN IMMUNOLOGY , vol.13 .
Tasli, N. P., GÖNEN, Z. B., Kirbas, O. K., Gokdemir, N. S., Bozkurt, B. T., Bayrakci, B., ... Sagrac, D.(2022). Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2. FRONTIERS IN IMMUNOLOGY , vol.13.
Tasli, Neslihan Et Al. "Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2," FRONTIERS IN IMMUNOLOGY , vol.13, 2022
Tasli, Neslihan P. Et Al. "Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2." FRONTIERS IN IMMUNOLOGY , vol.13, 2022
Tasli, N. P. Et Al. (2022) . "Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2." FRONTIERS IN IMMUNOLOGY , vol.13.
@article{article, author={Neslihan Pakize Tasli Et Al. }, title={Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2}, journal={FRONTIERS IN IMMUNOLOGY}, year=2022}